All | Non-MDA | MDA ≥ 5/7 | MDA 5/7 | MDA 6/7 | LDA 5–6/7 | VLDA 7/7 | Pa | |
---|---|---|---|---|---|---|---|---|
No. patients | 258 | 138 | 120 | 48 | 42 | 90 | 30 | |
Sex, male, % | 50.4 | 40.6 | 61.7 | 58.3 | 59.5 | 58.9 | 70.0 | 0.39 |
Age, yrs, mean ± SD | 50.7 ± 12.5 | 50.4 ± 12.9 | 51.0 ± 12.1 | 51.1 ± 12.7 | 51.5 ± 12.4 | 51.3 ± 12.5 | 50.0 ± 11.1 | 0.62b |
TJC ≤ 1/68 | 134 (51.9) | 36 (26.1) | 98 (81.7) | 32 (66.7) | 36 (85.7) | 68 (75.6) | 30 (100) | < 0.01 |
SJC ≤ 1/66 | 221 (85.7) | 105 (76.1) | 116 (96.7) | 44 (91.7) | 42 (100) | 86 (95.6) | 30 (100) | 0.57 |
LEI ≤ 1 | 227 (88.0) | 107 (77.5) | 120 (100) | 48 (100) | 42 (100) | 90 (100) | 30 (100) | 1.00 |
PASI ≤ 1 or BSA ≤ 3 | 179 (69.4) | 84 (60.9) | 95 (79.2) | 33 (68.8) | 32 (76.2) | 65 (72.2) | 30 (100) | < 0.01 |
Pain VAS ≤ 1.5 cm | 74 (28.7) | 5 (3.6) | 69 (57.5) | 13 (27.1) | 26 (61.9) | 39 (43.3) | 30 (100) | < 0.01 |
PtGA-VAS ≤ 2 cm | 116 (45.0) | 15 (10.9) | 101 (84.2) | 30 (62.5) | 41 (97.6) | 71 (78.9) | 30 (100) | < 0.01 |
HAQ-DI ≤ 0.5 | 134 (51.9) | 31 (22.5) | 103 (85.8) | 40 (83.3) | 33 (78.6) | 73 (81.1) | 30 (100) | < 0.01 |
Data are presented as n (% of patients) unless otherwise stated.
↵a LDA vs VLDA.
↵b By t test; chi-square test otherwise. BSA: body surface area; HAQ-DI: Health Assessment Questionnaire-Disability Index; LDA: low disease activity; LEI: Leeds Enthesitis Index; MDA: minimal disease activity; PASI: Psoriasis Area Severity Index; PtGA-VAS: patient global disease activity by VAS; SJC: swollen joint count; TJC: tender joint count; VAS: visual analog scale; VLDA: very low disease activity.